| JDINX | VDVIX | JDINX / VDVIX | |
| Total Expense Ratio | 0.69 | 0.16 | 431% |
| Annual Report Gross Expense Ratio | 0.69 | 0.16 | 431% |
| Fund Existence | 14 years | 13 years | - |
| Gain YTD | 17.230 | 16.722 | 103% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.69B | 324B | 1% |
| Annual Yield % from dividends | 1.20 | 2.37 | 50% |
| Returns for 1 year | 24.33 | 21.95 | 111% |
| Returns for 3 years | 67.85 | 63.48 | 107% |
| Returns for 5 years | 63.65 | 41.64 | 153% |
| Returns for 10 years | 195.60 | 110.42 | 177% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NWXQX | 17.57 | 0.15 | +0.86% |
| Nationwide Mid Cap Market Idx Instl Svc | |||
| VGSNX | 20.80 | 0.16 | +0.78% |
| Vanguard Real Estate Index Institutional | |||
| AVEEX | 18.17 | 0.12 | +0.66% |
| Avantis® Emerging Markets Equity Instl | |||
| FRVFX | 52.91 | 0.25 | +0.47% |
| Franklin Small Cap Value C | |||
| RYOAX | 71.89 | 0.12 | +0.17% |
| Rydex Biotechnology H | |||